3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
13
Myeloproliferative Disorders
3
Myelodysplastic Syndromes
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Lymphoma, Follicular
1
IDH1-Mutated Malignancies
1
Histiocytic Sarcoma
1
Chondrosarcoma
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Biliary Tract Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
paricalcitol
1
mitazalimab
1
Specimen Handling
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Losartan
1
Leucovorin
1
Irinotecan
1
Hydroxychloroquine
1
Glucose
1
Gemcitabine
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Contrast Media
1
Capecitabine
1
Biopsy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
ivosidenib
×
90 days
×
Clear all
No trials found.